Dalacin Vc 20 mg Vaginal cream
PDF Leaflet Revision Date: 12 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of symptomatic bacterial vaginosis in non-pregnant women.
Dosage (summary)
1 applicator full (5 grams) intravaginally once daily for 3 to 7 days.
Special Populations
- Geriatric use not established
- Children
Pregnancy & Breastfeeding
Not safe in pregnancy; avoid breastfeeding during treatment.
Key Drug Interactions
- Caution with neuromuscular blocking agents
Contraindications
- Hypersensitivity to clindamycin or lincomycin
- History of antibiotic-associated colitis
- Pregnancy and lactation
Common side effects
- Fungal infections
- Headache
- Abdominal pain
- Vulvovaginal candidiasis
Counselling Points
- Avoid vaginal intercourse and other vaginal products during treatment
- May weaken latex products for 72 hours post-treatment
Serious warnings
- Risk of pseudomembranous colitis
- May cause overgrowth of non-susceptible organisms
Important Disclaimer
The Dalacin Vc 20 mg Vaginal cream professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
